Axogen (AXGN) Current Deferred Revenue (2013 - 2020)
Axogen's (AXGN) quarterly Current Deferred Revenue came in at $14000.0 in Q3 2020, little changed year-on-year from $14000.0 in Q4 2019, and little changed quarter-over-quarter from $14000.0 in Q1 2020.
Axogen (AXGN) Current Deferred Revenue (2013 - 2020) Analysis & Trends
Axogen's Current Deferred Revenue history runs 8 years deep, the most recent figure standing at $14000.0 for Q3 2020.
- On a quarterly basis, Current Deferred Revenue changed 0.0% year-over-year to $14000.0 in Q3 2020; TTM through Sep 2020 was $14000.0, a 0.0% change from a year earlier, with the FY2019 full-year figure at $14000.0, down 22.22% from the prior year.
- Current Deferred Revenue was little changed at $14000.0 in Q3 2020 per AXGN's latest filing, from $14000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $43576.0 in Q3 2017 and bottomed at $14000.0 in Q3 2019.
- The 5-year median for Current Deferred Revenue is $25500.0 (2018), against an average of $25632.6.
- Across the five-year window, Current Deferred Revenue jumped 155.22% in 2016 and plunged 47.22% in 2018, its largest moves.
- Year by year, Current Deferred Revenue stood at $33282.0 in 2016, then fell by 3.85% to $32000.0 in 2017, then plunged by 43.75% to $18000.0 in 2018, then slipped by 22.22% to $14000.0 in 2019, then changed by 0.0% to $14000.0 in 2020.
- Per Business Quant, the three latest AXGN Current Deferred Revenue figures stand at $14000.0 (Q3 2020), $14000.0 (Q1 2020), and $14000.0 (Q4 2019).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Axogen | 2.05 Bn | 1.95 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 14,000.00 |
| Mar 31, 2020 | 14,000.00 |
| Dec 31, 2019 | 14,000.00 |
| Sep 30, 2019 | 14,000.00 |
| Jun 30, 2019 | 19,000.00 |
| Mar 31, 2019 | 24,000.00 |
| Dec 31, 2018 | 18,000.00 |
| Sep 30, 2018 | 23,000.00 |
| Jun 30, 2018 | 27,000.00 |
| Mar 31, 2018 | 32,136.00 |
| Dec 31, 2017 | 32,000.00 |
| Sep 30, 2017 | 43,576.00 |
| Jun 30, 2017 | 39,399.00 |
| Mar 31, 2017 | 35,250.00 |
| Dec 31, 2016 | 33,282.00 |
| Sep 30, 2016 | 36,032.00 |
| Jun 30, 2016 | 28,593.00 |
| Mar 31, 2016 | 14,118.00 |
| Dec 31, 2015 | 14,118.00 |
| Sep 30, 2015 | 14,118.00 |